172 related articles for article (PubMed ID: 12576709)
1. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A
J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of desmopressin acetate to reverse acetylsalicylic acid-induced coagulopathy in three dogs.
Di Mauro FM; Holowaychuk MK
J Vet Emerg Crit Care (San Antonio); 2013; 23(4):455-8. PubMed ID: 23855456
[TBL] [Abstract][Full Text] [Related]
3. Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument.
Callan MB; Giger U
Am J Vet Res; 2002 Dec; 63(12):1700-6. PubMed ID: 12492285
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
5. [Hemostatic control in platelet dysfunction and abnormality by DDAVP].
Mito M; Higuchi W; Fuse I; Hattori A; Shibata A
Nihon Rinsho; 1992 Feb; 50(2):355-9. PubMed ID: 1613990
[TBL] [Abstract][Full Text] [Related]
6. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair.
Vucelić D; Golubović M; Bjelović M
Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257
[TBL] [Abstract][Full Text] [Related]
7. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin (DDAVP) and hemostasis.
Lethagen S
Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
[TBL] [Abstract][Full Text] [Related]
9. Effects of desmopressin on hemostasis in patients with liver cirrhosis.
Agnelli G; Parise P; Levi M; Cosmi B; Nenci GG
Haemostasis; 1995; 25(5):241-7. PubMed ID: 7489963
[TBL] [Abstract][Full Text] [Related]
10. Desmopressin: a nontransfusional hemostatic agent.
Mannucci PM
Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
[TBL] [Abstract][Full Text] [Related]
11. Use of DDAVP in inherited and acquired platelet dysfunction.
DiMichele DM; Hathaway WE
Am J Hematol; 1990 Jan; 33(1):39-45. PubMed ID: 2293761
[TBL] [Abstract][Full Text] [Related]
12. Effect of desmopressin on immune-mediated haemorrhagic disorders due to canine monocytic ehrlichiosis: a preliminary study.
Giudice E; Giannetto C; Gianesella M
J Vet Pharmacol Ther; 2010 Dec; 33(6):610-4. PubMed ID: 21108506
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
Brassard JA; Meyers KM
Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin for the treatment of aspirin-induced platelet dysfunction.
Schulz-Stübner S
Neurocrit Care; 2011 Feb; 14(1):148. PubMed ID: 20717749
[No Abstract] [Full Text] [Related]
15. Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanisms.
Lethagen S; Rugarn P; Aberg M; Nilsson IM
Acta Chir Scand; 1990 Sep; 156(9):597-602. PubMed ID: 1702252
[TBL] [Abstract][Full Text] [Related]
16. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
[TBL] [Abstract][Full Text] [Related]
17. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
18. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
20. The effect of DDAVP and placebo on platelet function and prolonged bleeding time induced by oral acetyl salicylic acid intake in healthy volunteers.
Lethagen S; Rugarn P
Thromb Haemost; 1992 Jan; 67(1):185-6. PubMed ID: 1615477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
